Milestones

1. Leadership in European research with four active projects: RETENTION (H2020), STRATIFY-HF (HE), FH-EARLY (HE), and XiA (ERASMUS), securing ~€1.15 million in competitive funding and demonstrating high international competitiveness with 10 European proposals submitted in 2025, including the first application for an ERC Advanced Grant.
2. Strong track record in securing national funding: (i) a PDC project awarded in 2025 and multiple active initiatives from ISCIII and CIBERCV, and (ii) high activity in clinical research, with a significant number of active trials, more than 100 patients recruited, and follow-up of more than 150 patients.
3. Dr. José Luis Zamorano has been recognized for his career and exemplary professional conduct by the Medical Association (OMC) in its sixth edition and at the Healthcare Leadership Awards (Clinical Leadership category), presented by the Health and Communication Observatory.
4. Dr. Lucía Matute, leader of the young physicians of the Spanish Society of Cardiology (SEC), was elected as a member of the group's executive committee during the most recent SEC congress.
5. Sánchez A, Domínguez LM, Rosseel L, Nombela L, Pfister R, Amat I, Butter C, Di M, Cruz I, Freixa X, Swaans M, Wilde C, Cacela D, Sarnago F, del Trigo M, Estévez R, López JR, De Torres F, Montenegro M, Pérez R, Guzmán G, Pajín F, Mylotte D, Pan M, Kristoff C, Carrillo X, de la Torre JM, Ruiz V, Salido L, Parraga R, Altlhoff J, Fernández C, Guarracini S, López S, Abdul O, Lautenschläger L, Ramos R, Puri R, Zamorano JL. Bicaval TricValve Implantation in Patients With Severe Tricuspid Regurgitation: 1-Year Outcomes From the TricBicaval Registry. JACC-Cardiovasc. Interv. 2025;18(15): 1913-1924. DOI:10.1016/j.jcin.2025.06.023.